Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
505 Parnassus Ave
San Francisco, CA 94143Phone+1 415-353-2742- Is this information wrong?
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2002 - 2005
- New York University School of MedicineClass of 2002
Certifications & Licensure
- CA State Medical License 2016 - 2024
- TX State Medical License 2007 - 2017
Clinical Trials
- MM CAR-T to Upgrade Response BMTCTN1902 Start of enrollment: 2022 Jan 05
Roles: Contact
Publications & Presentations
PubMed
- Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis.Malek, A., Al-Juhaishi, T., Milton, D., Ramdial, J., Daher, M., Olson, A., Srour, S., Alatrash, G., Oran, B., Mehta, R., Khouri, I., Bashir, Q., Shah, N., Ciurea, S., ...> ;Bone Marrow Transplantation. 2024 Feb 14
- Outcomes of weight-based vs. fixed dose of Pembrolizumab among patients with non-small cell lung cancer.Lena Chaitesipaseut, Thach-Giao Truong, Fang Niu, Patrick Shin, Kavita Sharma, Joshua Smith, Rita L Hui, Shah, N.> ;Journal of Oncology Pharmacy Practice. 2023 Nov 21
- 2 citationsRandomized phase 2 study of digital life coaching during transplantation for myeloma.Rahul Banerjee, Chiung-Yu Huang, Chloe Ryan, Albert Lee, Kelly J Brassil, Jasmine Moore, Shagun Arora, Alfred Chung, Sandy W Wong, Jeffrey Wolf, Thomas Martin, Anand D...> ;Bone Marrow Transplantation. 2023 Dec 1
- Join now to see all
Journal Articles
- Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction DrugsKrina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature
Abstracts/Posters
- Germline Variation Predicts Treatment Response in Multiple MyelomaNina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Profiling the Cell Surface Landscape of Proteasome Inhibitor-Treated and _Resistant Multiple Myeloma to Guide Immunotherapy Targeting, Diagnosis, and BiologyNina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Cord Blood Regulatory T Cells Prevent Mutiple Myeloma Progression By Suppressing InflammationNina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- A Phase 1, Open-Label, Multi-Center, Dose Escalation and Dose Expansion Study of NKTR-255 As a Single Agent in Relapsed or Refractory Hematologic Malignancies and in C...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Immunotherapy in Myeloma61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Daratumumab (DARA) Plus Lenalidomide Versus Lenalidomide Alone As Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma (NDMM) after Frontline Autolo...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
- CAR T-cell Therapy Produces Deep, Sustained Remissions in Patients with Relapsed MyelomaFebruary 24th, 2021
- Dr. Shah Discusses Data on Ide-Cel and Melflufen, Both Granted Priority Review by FDAOctober 23rd, 2020
- New Class of Drug Appears to Extend Survival in Patients with Triple-Refractory Multiple MyelomaJuly 30th, 2020
- Join now to see all
Hospital Affiliations
- UCSF Medical CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: